Skip to main content
SIU 2026 Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench to Bedside
Bench to Bedside
SIU@U
SIU@U

    Jeremy Teoh

    Associate Professor
    The Chinese University of Hong Kong, Hong Kong

    FRCS(Urol), PhD, BM, BCh, MA

    Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Associate Professor of the Faculty of Medicine, The Chinese University of Hong Kong (CUHK). He is also the Director of Urology Centre, and Director of Robotic Services, at the CUHK Medical Centre. In 2021, he was awarded the Ten Outstanding Young Persons Award (Hong Kong) and the SIU-Innovators Award. In 2023, he was appointed as an Adjunct Professor at the Medical University of Vienna. In 2024, he received the World Chinese Urological Society Rising Star Award.

    Jeremy is an oncological surgeon with primary interest in bladder cancer. Previously, he conducted a randomised trial comparing between bipolar and monopolar transurethral resection of bladder tumour (TURBT) and showed that bipolar TURBT was able to achieve a higher detrusor sampling rate than monopolar TURBT. He has also developed a global consensus statement on en bloc resection of bladder tumour (ERBT). A total of 99 statements reached consensus and they have become the standard reference for urologists practising en bloc resection globally. Recently, he published the results of the EB-StaR study, which is a multi-centre randomised trial demonstrating that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% for patients with ≤3cm non-muscle-invasive bladder cancer (NMIBC). He is also leading a phase 2 clinical trial on modified en bloc resection for large bladder tumours (>3cm). He is currently serving as a panel member of the European Association of Urology (EAU) Guidelines on NMIBC and Upper Tract Urothelial Carcinoma.

    Disclosure information not submitted.

    Presentation(s):